We are live on ! Find out more
WS

Wedbush Securities Portfolio holdings

AUM $3.88B
1-Year Est. Return 32.38%
This Fund
S&P 500
This Quarter Est. Return
+13.85%
1 Year Est. Return
+32.38%
3 Year Est. Return
+99.93%
5 Year Est. Return
+115.9%
10 Year Est. Return
+395.26%
AUM
$1.14B
AUM Growth
+$97.6M
Cap. Flow
-$16.4M
Cap. Flow %
-1.44%
Top 10 Hldgs %
20.55%
Holding
1,047
New
117
Increased
379
Reduced
323
Closed
176

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Consumer Discretionary 9.64%
3 Healthcare 9.06%
4 Financials 8.14%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAX
851
abrdn Asia-Pacific Income Fund
FAX
$595M
$56K ﹤0.01%
2,100
+3
+0.1% +$74
EFOI icon
852
Energy Focus
EFOI
$18M
$48K ﹤0.01%
1,714
GALT icon
853
Galectin Therapeutics
GALT
$213M
$46K ﹤0.01%
20,498
+3,000
+17% +$7.87K
SIEN
854
DELISTED
Sientra, Inc.
SIEN
$45K ﹤0.01%
1,150
MITT
855
TPG Mortgage Investment Trust
MITT
$231M
$43K ﹤0.01%
4,860
-2,989
-38% -$26.7K
TRT
856
Trio-Tech International
TRT
$98.1M
$41K ﹤0.01%
20,818
MNKD icon
857
MannKind Corp
MNKD
$1.2B
$33K ﹤0.01%
10,500
-1,000
-9% -$2.62K
DSWL icon
858
Deswell Industries
DSWL
$54.5M
$32K ﹤0.01%
11,100
TRVN
859
DELISTED
Trevena, Inc.
TRVN
$30K ﹤0.01%
23
-102
-82% -$162K
MUX icon
860
McEwen Inc
MUX
$1.02B
$20K ﹤0.01%
2,045
+45
+2% +$460
NMTR
861
DELISTED
9 Meters Biopharma
NMTR
$9K ﹤0.01%
+500
New +$8.34K
ABEO icon
862
Abeona Therapeutics
ABEO
$341M
-3,068
Closed -$78K
ACB
863
Aurora Cannabis
ACB
$168M
-3,000
Closed -$139K
ADTX
864
DELISTED
ADITXT INC
ADTX
0
-$121K
AKBA icon
865
Akebia Therapeutics
AKBA
$338M
-11,500
Closed -$29K
AKTX
866
Akari Therapeutics
AKTX
$14.9M
-39
Closed -$55K
AMRN
867
Amarin Corp
AMRN
$293M
-583
Closed -$49K
ANSS
868
DELISTED
Ansys
ANSS
-1,169
Closed -$383K
AQST icon
869
Aquestive Therapeutics
AQST
$465M
-103,240
Closed -$501K
ARI
870
Apollo Commercial Real Estate
ARI
$883M
-10,785
Closed -$97K
ARMP icon
871
Armata Pharmaceuticals
ARMP
$172M
-10,103
Closed -$32K
AXR icon
872
AMREP Corp
AXR
$122M
-51,882
Closed -$291K
BAC.PRL icon
873
Bank of America Series L
BAC.PRL
$3.97B
-555
Closed -$826K
BCML icon
874
BayCom
BCML
$334M
-35,647
Closed -$367K
BDRX
875
Biodexa Pharmaceuticals
BDRX
$1.3M
0
-$25K

Similar funds

Wedbush Securities's Q4 2020 Portfolio in Review

As of Q4 2020, Wedbush Securities held 1,047 positions worth $1.14B, up 9.4% from $1.04B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Wedbush Securities's Q4 2020 filing shows 117 new, 379 increased, 323 reduced and 176 closed positions. Its largest new stake was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $5.76M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Wedbush Securities's largest Q4 2020 buy was Cohen & Steers Tax-Advantaged Preferred Securities & Income Fund: 284,367 shares worth $7.39M.
  • Wedbush Securities added most to Microsoft in Q4 2020, an estimated $2.09M increase.
  • Wedbush Securities's biggest Q4 2020 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $5.76M.
  • Wedbush Securities fully exited First Trust Large Cap Growth AlphaDEX Fund in Q4 2020, selling an estimated $3.82M.
  • Wedbush Securities's ten largest holdings make up 21% of its $1.14B portfolio in Q4 2020.
  • Wedbush Securities opened 117 new positions and closed 176 in Q4 2020.
  • Wedbush Securities's portfolio value rose 9.4% quarter-over-quarter to $1.14B.

Based on Wedbush Securities's 13F filing for Q4 2020, filed 16 Feb 2021.